Aurolife Pharma, LLC recalls Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 60000-409-53); b…

Recall date

August 23, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1865-2019

FDA classification

Class II

Brand / firm

Aurolife Pharma, LLC

Sold / distributed

Nationwide in the USA

Why it was recalled

Failed Impurities/Degradation Specifications

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 60000-409-53); b) 30-count cartons (NDC 60000-409-30); c) 45-count bonus cartons (NDC 60000-409-48); d) 45-count cartons (NDC 60000-409-45); CAREone, Distributed by: Foodhold U.S.A., LLC, Landover, MD 20785.